Skip to main content
Full access
LETTER
Published Online: 1 July 2007

Is the Migraine Headache Ameliorated by Enhancing Chloride Current?

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
SIR: Blood vessels respond to transmural pressure elevation with constriction and to pressure reduction with dilation. This behavior, which is called myogenic response, is believed to play a central role in the maintenance of constant blood flow and capillary hydrostatic pressure (P c ) during variations in systemic arterial pressure. 1
Kitamura and Yamazaki 2 have postulated that stretching the vessel wall by increased blood pressure activates the volume regulated Cl channels. This probably causes the membrane to become depolarized and consequently to activate L -type Ca 2+ channels and reduce the arterial diameter.
On the other hand, the autoregulation of cerebral hydrostatic pressure is completely different in migraine patients compared with healthy subjects and it seems that myogenic cerebrovascular autoregulation is disturbed in some kinds of migraines. 3, 4
It may be possible that Cl channels contribute to migraine disease. We propose that some of the symptoms of migraine headaches may be cured by enhancing Cl channel currents. In accordance with our hypothesis, Smith et al. 5 mentioned that BTS 72664, which enhances chloride currents through picrotoxin-sensitive chloride channels, is likely to have antimigraine activity. Surely, experimental and clinical research is needed to verify this hypothesis.

References

1.
Davis MJ, Hill MA: Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999; 79:387–423
2.
Kitamura K, Yamazaki J: Chloride channels and their functional roles in smooth muscle tone in the vasculature. Jpn J Pharmacol 2001; 85:351–357
3.
Muller M, Marziniak M: The linear behavior of the system middle cerebral artery flow velocity and blood pressure in patients with migraine: lack of autonomic control? Stroke 2005; 36:1886–1890
4.
Heckmann JG, Hilz MJ, Katalinic A, et al: Myogenic cerebrovascular auto regulation in migraine measured by stress transcranial Doppler sonography. Cephalalgia 1998; 18:133–137
5.
Smith SL, Thompson KS, Sargent BJ, et al: BTS 72664: a novel CNS drug with potential anticonvulsant, neuroprotective, and antimigraine properties. CNS Drug Rev 2001; 7:146–171

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 340 - 341
PubMed: 17827424

History

Published online: 1 July 2007
Published in print: Summer, 2007

Authors

Details

Shahriar Gharibzadeh, M.D., Ph.D.
Aboozar Taherkhani, M.Sc.
Mohammad Sadeghzadeh, M.Sc.
Neuromuscular Systems Laboratory, Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share